董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Robert S. Weiss | 男 | Chairman | 77 | 47.18万美元 | 20.49 | 2024-02-02 |
| Albert G. White III | 男 | President & Chief Executive Officer and Director | 54 | 1349.09万美元 | 39.80 | 2024-02-02 |
| Colleen E. Jay | 女 | Director | 61 | 33.99万美元 | 0.77 | 2024-02-02 |
| William A. Kozy | 男 | Lead Director | 72 | 36.84万美元 | 0.81 | 2024-02-02 |
| Teresa S. Madden | 女 | Director | 67 | 34.49万美元 | 0.17 | 2024-02-02 |
| Maria Rivas | 女 | Director | 60 | 31.99万美元 | 0.11 | 2024-02-02 |
| Cynthia L. Lucchese | 女 | Director | 63 | 31.16万美元 | 0.05 | 2024-02-02 |
| Lawrence E. Kurzius | 男 | Director | 65 | 未披露 | 未持股 | 2024-02-02 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Albert G. White III | 男 | President & Chief Executive Officer and Director | 54 | 1349.09万美元 | 39.80 | 2024-02-02 |
| Brian G. Andrews | 男 | Executive Vice President, Chief Financial Officer & Treasurer | 45 | 347.20万美元 | 7.05 | 2024-02-02 |
| Holly R. Sheffield | 女 | President , CooperSurgical , Inc. | 53 | 321.96万美元 | 7.04 | 2024-02-02 |
| Gerard H. Warner III | 男 | President , CooperVision , Inc. | 59 | 278.01万美元 | 1.46 | 2024-02-02 |
| Daniel G. Mcbride | 男 | Executive Vice President & Chief Operating Officer | 59 | 437.81万美元 | 17.78 | 2024-02-02 |
董事简历
中英对照 | 中文 | 英文- Robert S. Weiss
-
Robert S. Weiss自2007年1月以来担任The Cooper Companies, Inc.的董事会成员。自2007年11月以来他担任全球专业医疗产品公司The Cooper Companies, Inc.的首席执行官。他在2008年3月担任Cooper的总裁。自1989年以来他在Cooper担任各种高级管理职位。他从2005年1月到2007年10月担任Cooper的执行副总裁兼首席运营官，从2007年3月至2008年3月他担任CooperVision（Cooper隐形眼镜子公司）的总裁。在此之前，他从1989年9月到2005年1月担任Cooper的首席财务官，从1995年10月到2007年11月还担任执行副总裁。从1984年3月到1995年10月他在Cooper担任其他各种职位，包括高级副总裁、副总裁和公司财务总监。自1996年以来他在Cooper的董事会工作。他获得犹他大学（the University of Utah）的会计学士学位。
Robert S. Weiss,served as The Cooper Companies, Inc. President from March 2008 and as The Cooper Companies, Inc. Chief Executive Officer from November 2007 until his retirement in May 2018. He also served as President of CooperVision, The Cooper Companies, Inc. contact lens subsidiary, from March 2007 to February 2008. He previously served as The Cooper Companies, Inc. Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as The Cooper Companies, Inc. Chief Financial Officer from September 1989 to January 2005. He served as The Cooper Companies, Inc. Treasurer from 1989 to March 2002. Since joining The Cooper Companies, Inc. in 1977, he has held a number of finance positions both with The Cooper Companies, Inc. and Cooper Laboratories, Inc. - Robert S. Weiss自2007年1月以来担任The Cooper Companies, Inc.的董事会成员。自2007年11月以来他担任全球专业医疗产品公司The Cooper Companies, Inc.的首席执行官。他在2008年3月担任Cooper的总裁。自1989年以来他在Cooper担任各种高级管理职位。他从2005年1月到2007年10月担任Cooper的执行副总裁兼首席运营官，从2007年3月至2008年3月他担任CooperVision（Cooper隐形眼镜子公司）的总裁。在此之前，他从1989年9月到2005年1月担任Cooper的首席财务官，从1995年10月到2007年11月还担任执行副总裁。从1984年3月到1995年10月他在Cooper担任其他各种职位，包括高级副总裁、副总裁和公司财务总监。自1996年以来他在Cooper的董事会工作。他获得犹他大学（the University of Utah）的会计学士学位。
- Robert S. Weiss,served as The Cooper Companies, Inc. President from March 2008 and as The Cooper Companies, Inc. Chief Executive Officer from November 2007 until his retirement in May 2018. He also served as President of CooperVision, The Cooper Companies, Inc. contact lens subsidiary, from March 2007 to February 2008. He previously served as The Cooper Companies, Inc. Chief Operating Officer from January 2005 to October 2007 and as Executive Vice President from October 1995 to October 2007. He served as The Cooper Companies, Inc. Chief Financial Officer from September 1989 to January 2005. He served as The Cooper Companies, Inc. Treasurer from 1989 to March 2002. Since joining The Cooper Companies, Inc. in 1977, he has held a number of finance positions both with The Cooper Companies, Inc. and Cooper Laboratories, Inc.
- Albert G. White III
-
Albert G. White III，2011年7月以来一直担任首席战略官；在2006年4月加入公司以来任副总裁。他之前从2007年11月到2007年3月担任副总裁，负责投资者关系。他还从2006年4月到2006年12月担任会计。在加入公司之前，他曾担任KeyBanc资本市场主管达三年，前八年在KeyBank全国协会担任领导职务。
Albert G. White III,has served as President & Chief Executive Officer and a member of The Cooper Companies, Inc. Board of Directors since May 2018. Previously, he served as Chief Financial Officer from November 2016 until his appointment as CEO and he also served as Executive Vice President and Chief Strategy Officer, positions he held from December 2015 and July 2011, respectively. From August 2015 to May 2018, Mr. White also directed The Cooper Companies, Inc. women's healthcare business and served as Chief Executive Officer of Cooper Medical Inc., the parent company to CooperSurgical. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years. - Albert G. White III，2011年7月以来一直担任首席战略官；在2006年4月加入公司以来任副总裁。他之前从2007年11月到2007年3月担任副总裁，负责投资者关系。他还从2006年4月到2006年12月担任会计。在加入公司之前，他曾担任KeyBanc资本市场主管达三年，前八年在KeyBank全国协会担任领导职务。
- Albert G. White III,has served as President & Chief Executive Officer and a member of The Cooper Companies, Inc. Board of Directors since May 2018. Previously, he served as Chief Financial Officer from November 2016 until his appointment as CEO and he also served as Executive Vice President and Chief Strategy Officer, positions he held from December 2015 and July 2011, respectively. From August 2015 to May 2018, Mr. White also directed The Cooper Companies, Inc. women's healthcare business and served as Chief Executive Officer of Cooper Medical Inc., the parent company to CooperSurgical. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.
- Colleen E. Jay
-
Colleen E. Jay，目前担任Catalyst, Inc.（一个非盈利组织，致力于改善女性的职场包容的公司）的租借高管。她从Procter & Gamble（NYSE：PG，一个美国跨国消费品公司）借调。她于2016年10月担任Catalyst公司的贷款执行官，也曾担任Procter & Gamble的美容专业业务总裁（始于2015年），也曾负责威娜专业沙龙、化妆品、零售染发和香水业务。担任美容专业业务领导之前，她曾领导Procter & Gamble公司的全球零售护发和颜色部门（2012年至2015年），以及全球女性美容部门（从2010年到2012年）。她也曾担任副总裁兼总经理，负责大中华区女性护理、个人清洁、口腔护理和整个中国营销功能（2006年至2009年），在那里她曾负责总价值超过10亿美元的业务。她曾担任Procter & Gamble公司的多种职务（1985年7月以来），并在职业生涯中也曾领导美国、加拿大、中国和瑞士运营单位，包括全球领先企业。
Colleen E. Jay,served as a Global Division President for Procter and Gamble until her retirement in October 2017. Her most recent operational assignment was President, Global Beauty Specialty Business at Procter & Gamble from 2015 where she was responsible for the Wella Professional Salon, Cosmetics, Retail Hair Color, and Fragrance businesses, and the successful divestiture of them.Prior to that, Ms. Jay led the multi-billion dollar Global Retail Hair Care and Color division of Procter & Gamble from 2012 to 2015 and the Global Female Beauty division from 2010 to 2012. She also served as Vice President & General Manager, Greater China Feminine Care, Personal Cleansing, Oral Care & Entire China Marketing Function, based in Guangzhou, China, from 2006 to 2009, where she was responsible for businesses with a combined value of over $1 billion.She worked in various positions with Procter & Gamble since July 1985 and has led operational units in the United States, Canada, China, and Switzerland (including leading global businesses) during the course of her career. Ms. Jay has also volunteered at Catalyst, Inc., a non-profit organization dedicated to improving workplace inclusion for women. - Colleen E. Jay，目前担任Catalyst, Inc.（一个非盈利组织，致力于改善女性的职场包容的公司）的租借高管。她从Procter & Gamble（NYSE：PG，一个美国跨国消费品公司）借调。她于2016年10月担任Catalyst公司的贷款执行官，也曾担任Procter & Gamble的美容专业业务总裁（始于2015年），也曾负责威娜专业沙龙、化妆品、零售染发和香水业务。担任美容专业业务领导之前，她曾领导Procter & Gamble公司的全球零售护发和颜色部门（2012年至2015年），以及全球女性美容部门（从2010年到2012年）。她也曾担任副总裁兼总经理，负责大中华区女性护理、个人清洁、口腔护理和整个中国营销功能（2006年至2009年），在那里她曾负责总价值超过10亿美元的业务。她曾担任Procter & Gamble公司的多种职务（1985年7月以来），并在职业生涯中也曾领导美国、加拿大、中国和瑞士运营单位，包括全球领先企业。
- Colleen E. Jay,served as a Global Division President for Procter and Gamble until her retirement in October 2017. Her most recent operational assignment was President, Global Beauty Specialty Business at Procter & Gamble from 2015 where she was responsible for the Wella Professional Salon, Cosmetics, Retail Hair Color, and Fragrance businesses, and the successful divestiture of them.Prior to that, Ms. Jay led the multi-billion dollar Global Retail Hair Care and Color division of Procter & Gamble from 2012 to 2015 and the Global Female Beauty division from 2010 to 2012. She also served as Vice President & General Manager, Greater China Feminine Care, Personal Cleansing, Oral Care & Entire China Marketing Function, based in Guangzhou, China, from 2006 to 2009, where she was responsible for businesses with a combined value of over $1 billion.She worked in various positions with Procter & Gamble since July 1985 and has led operational units in the United States, Canada, China, and Switzerland (including leading global businesses) during the course of her career. Ms. Jay has also volunteered at Catalyst, Inc., a non-profit organization dedicated to improving workplace inclusion for women.
- William A. Kozy
-
William A. Kozy，他曾担任Becton Dickinson（NYSE：BDX）的首席运营官（2012年至2016年退休），以及执行副总裁（2006年至2016年）。他也曾担任Becton Dickinson的公司领导团队的成员，以及多种执行职务（1988年以来），包括高级副总裁，负责公司运营（1998年至2002年）、BD Diagnostics的总裁（2002年至2006年）、BD Biosciences部门的总裁（2006年至2009年），BD Medical公司的主管（2009年至2011年）。他继续担任the Center for Becton Dickinson Leadership的活跃荣誉教职工成员，从事公司的领导力发展。他是the Hackensack Meridian Health Board of Governors的成员，在那里他任职于战略规划和高管薪酬委员会。他也任职于the Franciscan Sisters of the Poor Foundation的董事会。他是the Karen Ann Quinlan Hospice、the Immokalee Child Care Center （位于弗罗里达那不勒斯）的活跃的捐助者和志愿者。
William A. Kozy,served as the Chief Operating Officer of Becton Dickinson (NYSE: BDX) from 2012 until his retirement in 2016, and as its Executive Vice President from 2006 until 2016. He also served as a member of the corporate Leadership Team for Becton Dickinson and in various executive roles since 1988, including Senior Vice President of Company Operations from 1998 until 2002, President of BD Diagnostics from 2002 through 2006, President of the BD Biosciences segment from 2006 to 2009 and head of BD Medical from 2009 through 2011. - William A. Kozy，他曾担任Becton Dickinson（NYSE：BDX）的首席运营官（2012年至2016年退休），以及执行副总裁（2006年至2016年）。他也曾担任Becton Dickinson的公司领导团队的成员，以及多种执行职务（1988年以来），包括高级副总裁，负责公司运营（1998年至2002年）、BD Diagnostics的总裁（2002年至2006年）、BD Biosciences部门的总裁（2006年至2009年），BD Medical公司的主管（2009年至2011年）。他继续担任the Center for Becton Dickinson Leadership的活跃荣誉教职工成员，从事公司的领导力发展。他是the Hackensack Meridian Health Board of Governors的成员，在那里他任职于战略规划和高管薪酬委员会。他也任职于the Franciscan Sisters of the Poor Foundation的董事会。他是the Karen Ann Quinlan Hospice、the Immokalee Child Care Center （位于弗罗里达那不勒斯）的活跃的捐助者和志愿者。
- William A. Kozy,served as the Chief Operating Officer of Becton Dickinson (NYSE: BDX) from 2012 until his retirement in 2016, and as its Executive Vice President from 2006 until 2016. He also served as a member of the corporate Leadership Team for Becton Dickinson and in various executive roles since 1988, including Senior Vice President of Company Operations from 1998 until 2002, President of BD Diagnostics from 2002 through 2006, President of the BD Biosciences segment from 2006 to 2009 and head of BD Medical from 2009 through 2011.
- Teresa S. Madden
-
Teresa S. Madden从2011年至2016年退休，担任电力和天然气公用事业XCEL Energy，Inc.（NASDAQ：XEL）的执行副总裁兼首席财务官。她于2003年加入XCEL，担任财务、客户和外地业务副总裁，并于2004年被任命为副总裁兼财务总监。她曾于2000年至2003年担任Rogue Wave Software，Inc.的财务总管；2004年1月到2011年9月担任Xcel能源服务有限公司副总裁和总监并担任XCEL Energy前身公司科罗拉多新世纪能源和公共服务公司的财务总管，自2011年9月至今担任Xcel能源服务有限公司高级副总裁和首席财务官。Madden女士拥有科罗拉多州立大学会计学学士学位和里吉斯大学工商管理硕士学位。Madden女士在Enbridge，Inc.（NYSE：ENB）董事会任职，并担任治理委员会成员和审计主席，财务和风险委员会，此前她曾在2017年至2020年担任皮博迪能源公司（NYSE：BTU）董事，曾在健康、安全、安保和环境委员会任职，并担任审计委员会主席。
Teresa S. Madden,served as Executive Vice President and Chief Financial Officer of Xcel Energy, Inc. (NASDAQ:XEL), an electric and natural gas utility, from 2011 until her retirement in 2016. She joined Xcel in 2003 as Vice President, Finance, Customer & Field Operations and was named Vice President and Controller in 2004. Previously, she served as Controller for Rogue Wave Software, Inc. from 2000 to 2003 and as Controller for New Century Energies and Public Service Company of Colorado, predecessor companies of Xcel Energy. Ms. Madden holds a Bachelor of Science in Accounting from Colorado State University and a Master of Business Administration from Regis University. - Teresa S. Madden从2011年至2016年退休，担任电力和天然气公用事业XCEL Energy，Inc.（NASDAQ：XEL）的执行副总裁兼首席财务官。她于2003年加入XCEL，担任财务、客户和外地业务副总裁，并于2004年被任命为副总裁兼财务总监。她曾于2000年至2003年担任Rogue Wave Software，Inc.的财务总管；2004年1月到2011年9月担任Xcel能源服务有限公司副总裁和总监并担任XCEL Energy前身公司科罗拉多新世纪能源和公共服务公司的财务总管，自2011年9月至今担任Xcel能源服务有限公司高级副总裁和首席财务官。Madden女士拥有科罗拉多州立大学会计学学士学位和里吉斯大学工商管理硕士学位。Madden女士在Enbridge，Inc.（NYSE：ENB）董事会任职，并担任治理委员会成员和审计主席，财务和风险委员会，此前她曾在2017年至2020年担任皮博迪能源公司（NYSE：BTU）董事，曾在健康、安全、安保和环境委员会任职，并担任审计委员会主席。
- Teresa S. Madden,served as Executive Vice President and Chief Financial Officer of Xcel Energy, Inc. (NASDAQ:XEL), an electric and natural gas utility, from 2011 until her retirement in 2016. She joined Xcel in 2003 as Vice President, Finance, Customer & Field Operations and was named Vice President and Controller in 2004. Previously, she served as Controller for Rogue Wave Software, Inc. from 2000 to 2003 and as Controller for New Century Energies and Public Service Company of Colorado, predecessor companies of Xcel Energy. Ms. Madden holds a Bachelor of Science in Accounting from Colorado State University and a Master of Business Administration from Regis University.
- Maria Rivas
-
Maria Rivas目前担任the healthcare business of Merck KGaA, Darmstadt的首席医疗官和高级副总裁。the healthcare business of Merck KGaA, Darmstadt在美国和加拿大担任EMD Serono，领导全球90多个国家的药物警戒、医疗事务和证据与价值开发（HEOR）团队。Rivas博士在推动高度监管行业的增长和商业化战略、全球运营、数字转型以及危机和风险管理方面有经验。在此之前，Rivas博士曾担任默克公司（MSD）全球医疗事务高级副总裁、Abbvie全球医疗事务副总裁、拜耳医疗集团肿瘤学、普通医学和诊断成像医学事务副总裁，在礼来担任各种职务，包括美国妇女健康医疗事务负责人。在加入礼来公司之前，Rivas博士在波多黎各私人执业，担任内分泌学家。Rivas博士在马萨诸塞州沃尔瑟姆的布兰代斯大学获得了生物化学学士学位，并在纽约哥伦比亚大学瓦杰洛斯内科医生和外科医生学院获得了医学博士学位。她在纽约州纽约长老会医院完成了内科住院医师和内分泌学奖学金。Rivas博士获得了内分泌学、糖尿病和新陈代谢委员会认证。
Maria Rivas,currently serves as Global Chief Medical Affairs Officer and Head, Evidence Generation for Pfizer, Inc. (NYSE: PFE). Until September 2022, she served as Chief Medical Officer and Senior Vice President for the healthcare business of Merck KGaA, Darmstadt, Germany (which operates as EMD Serono in the US and Canada) where she led the Global Pharmacovigilance, Medical Affairs and Evidence and Value Development (HEOR) teams in over 90 countries. Dr. Rivas has extensive experience in driving growth and commercialization strategies, global operations, digital transformation, and crisis and risk management in highly regulated industries.Prior to that, Dr. Rivas served as Senior Vice President of Global Medical Affairs at Merck & Co (MSD), as Vice President of Global Medical Affairs at AbbVie, as Vice President of Oncology, General Medicine and Diagnostic Imaging Medical Affairs at Bayer Healthcare, and in various roles at Eli Lilly including Head of US Women's Health Medical Affairs. Before joining Eli Lilly, Dr. Rivas was in private practice as an endocrinologist in Puerto Rico.Dr. Rivas obtained a BA in Biochemistry from Brandeis University, Waltham, MA and an MD from Columbia University's Vagelos College of Physicians and Surgeons, New York, NY. She completed a residency in Internal Medicine and a fellowship in Endocrinology at NY-Presbyterian Hospital, New York, NY. Dr. Rivas is board certified in Endocrinology, Diabetes and Metabolism. - Maria Rivas目前担任the healthcare business of Merck KGaA, Darmstadt的首席医疗官和高级副总裁。the healthcare business of Merck KGaA, Darmstadt在美国和加拿大担任EMD Serono，领导全球90多个国家的药物警戒、医疗事务和证据与价值开发（HEOR）团队。Rivas博士在推动高度监管行业的增长和商业化战略、全球运营、数字转型以及危机和风险管理方面有经验。在此之前，Rivas博士曾担任默克公司（MSD）全球医疗事务高级副总裁、Abbvie全球医疗事务副总裁、拜耳医疗集团肿瘤学、普通医学和诊断成像医学事务副总裁，在礼来担任各种职务，包括美国妇女健康医疗事务负责人。在加入礼来公司之前，Rivas博士在波多黎各私人执业，担任内分泌学家。Rivas博士在马萨诸塞州沃尔瑟姆的布兰代斯大学获得了生物化学学士学位，并在纽约哥伦比亚大学瓦杰洛斯内科医生和外科医生学院获得了医学博士学位。她在纽约州纽约长老会医院完成了内科住院医师和内分泌学奖学金。Rivas博士获得了内分泌学、糖尿病和新陈代谢委员会认证。
- Maria Rivas,currently serves as Global Chief Medical Affairs Officer and Head, Evidence Generation for Pfizer, Inc. (NYSE: PFE). Until September 2022, she served as Chief Medical Officer and Senior Vice President for the healthcare business of Merck KGaA, Darmstadt, Germany (which operates as EMD Serono in the US and Canada) where she led the Global Pharmacovigilance, Medical Affairs and Evidence and Value Development (HEOR) teams in over 90 countries. Dr. Rivas has extensive experience in driving growth and commercialization strategies, global operations, digital transformation, and crisis and risk management in highly regulated industries.Prior to that, Dr. Rivas served as Senior Vice President of Global Medical Affairs at Merck & Co (MSD), as Vice President of Global Medical Affairs at AbbVie, as Vice President of Oncology, General Medicine and Diagnostic Imaging Medical Affairs at Bayer Healthcare, and in various roles at Eli Lilly including Head of US Women's Health Medical Affairs. Before joining Eli Lilly, Dr. Rivas was in private practice as an endocrinologist in Puerto Rico.Dr. Rivas obtained a BA in Biochemistry from Brandeis University, Waltham, MA and an MD from Columbia University's Vagelos College of Physicians and Surgeons, New York, NY. She completed a residency in Internal Medicine and a fellowship in Endocrinology at NY-Presbyterian Hospital, New York, NY. Dr. Rivas is board certified in Endocrinology, Diabetes and Metabolism.
- Cynthia L. Lucchese
-
Cynthia L. Lucchese， 2008年2月8日被选为高级副总裁和首席财务官。从2005年到2007年担任 Thoratec公司高级副总裁和首席财务官。在那之前，她在Guidant 公司（现在是波士顿技术公司的一部分）工作10年，担任多个高级金融职位，包括副总裁和风险官；企业总监和首席会计官；金融副总裁和Guidant销售公司行政总监。她之前曾在礼来公司和安永会计师事务所工作。
Cynthia L. Lucchese is the Chief Administrative Officer and Chief Financial Officer of Hulman & Company, a privately held company headquartered in Indianapolis, Indiana, which owns and operates the Indianapolis Motor Speedway, INDYCAR racing league, Indianapolis Motor Speedway Productions, Clabber Girl Corporation and various real estate holdings. Prior to joining Hulman, Ms. Lucchese was Senior Vice President and Chief Financial Officer of Hillenbrand, Inc., where from 2008 to 2014 she was a key member of the leadership team that transformed Hillenbrand from a $650 million North American business to a $1.6 billion global diversified industrial company. She also has extensive experience in the medical device industry, including serving from 2005 to 2007 as Senior Vice President and Chief Financial Officer of Thoratec Corporation, a medical device company focused on treating advanced stage heart failure. Ms. Lucchese also held various senior financial positions with Guidant Corporation, now a part of Boston Scientific Corporation, from 1994 to 2005 including Vice President and Treasurer, Vice President of Finance and Administration - Guidant Sales Corporation, and Vice President - Controller and Chief Accounting Officer. Since July 2014 Ms. Lucchese has served as a member of the Board of Directors, a member of the Nominating & Corporate Governance Committee and Chairman of the Audit Committee of Intersect ENT, Inc. In June 2017 she joined the Board of Directors of Beaver-Visitec, Inc., and serves as Chairman of the Audit Committee. She previously served as a member of the Board of Directors of Brightpoint, Inc. from 2009 to 2012 serving as Chairman of the Audit Committee. In addition, she currently also serves as a member of the Dean's Council for the Kelley School of Business of Indiana University. - Cynthia L. Lucchese， 2008年2月8日被选为高级副总裁和首席财务官。从2005年到2007年担任 Thoratec公司高级副总裁和首席财务官。在那之前，她在Guidant 公司（现在是波士顿技术公司的一部分）工作10年，担任多个高级金融职位，包括副总裁和风险官；企业总监和首席会计官；金融副总裁和Guidant销售公司行政总监。她之前曾在礼来公司和安永会计师事务所工作。
- Cynthia L. Lucchese is the Chief Administrative Officer and Chief Financial Officer of Hulman & Company, a privately held company headquartered in Indianapolis, Indiana, which owns and operates the Indianapolis Motor Speedway, INDYCAR racing league, Indianapolis Motor Speedway Productions, Clabber Girl Corporation and various real estate holdings. Prior to joining Hulman, Ms. Lucchese was Senior Vice President and Chief Financial Officer of Hillenbrand, Inc., where from 2008 to 2014 she was a key member of the leadership team that transformed Hillenbrand from a $650 million North American business to a $1.6 billion global diversified industrial company. She also has extensive experience in the medical device industry, including serving from 2005 to 2007 as Senior Vice President and Chief Financial Officer of Thoratec Corporation, a medical device company focused on treating advanced stage heart failure. Ms. Lucchese also held various senior financial positions with Guidant Corporation, now a part of Boston Scientific Corporation, from 1994 to 2005 including Vice President and Treasurer, Vice President of Finance and Administration - Guidant Sales Corporation, and Vice President - Controller and Chief Accounting Officer. Since July 2014 Ms. Lucchese has served as a member of the Board of Directors, a member of the Nominating & Corporate Governance Committee and Chairman of the Audit Committee of Intersect ENT, Inc. In June 2017 she joined the Board of Directors of Beaver-Visitec, Inc., and serves as Chairman of the Audit Committee. She previously served as a member of the Board of Directors of Brightpoint, Inc. from 2009 to 2012 serving as Chairman of the Audit Committee. In addition, she currently also serves as a member of the Dean's Council for the Kelley School of Business of Indiana University.
- Lawrence E. Kurzius
-
Lawrence E. Kurzius是Global Consumer Business公司的总裁兼首席行政官（2013年至今），也是 McCormick International 公司的总裁（2008年至2013年）。
Lawrence E. Kurzius,serves as the Chairman (since 2017) and Chief Executive Officer of McCormick (since 2016). He previously served as President as well (from 2015 until 2022) and in a variety of other roles with the Company, thereby gaining an understanding of the different aspects of the Company's operations and the food industry. Prior to assuming his present role, Mr. Kurzius was (a) President and Chief Operating Officer (2015 to 2016) of McCormick, (b) President of the Company's global consumer business (2013 to 2016), (c) Chief Administrative Officer of the Company (2013 to 2015), (d) President of the Company's international business (2008 to 2013), (e) President of EMEA (2007 to 2008), (f) President of U.S. Consumer Foods (2005 to 2007), (g) Vice President and General Manager of Sales and Marketing for U.S. Consumer Foods (2005), and (h) President of Zatarain's (2003 to 2005). Prior to joining the Company upon the acquisition of Zatarain's by McCormick, Mr. Kurzius was the Chief Executive Officer of Zatarain's where he worked for 12 years. Mr. Kurzius was also a marketing executive with the Quaker Oats Company and Mars Inc.'s Uncle Ben's Company. In these various roles, Mr. Kurzius developed a broad knowledge of the Company's markets – both domestic and international, and consumer and flavor solutions – and had senior level responsibility for strategic planning and leadership with respect to these businesses. In his present role, Mr. Kurzius is responsible for the strategic leadership of the Company. He has extensive knowledge of consumer goods marketing in general, with a specific knowledge of the business, markets, and customers within the food industry in particular, and has hands-on experience in directing the day-to-day operations of Mccormick & Company, Incorporated large, multi-faceted, consumer and flavor solutions foods business. Mr. Kurzius currently serves on the board of Elanco Animal Health Inc. - Lawrence E. Kurzius是Global Consumer Business公司的总裁兼首席行政官（2013年至今），也是 McCormick International 公司的总裁（2008年至2013年）。
- Lawrence E. Kurzius,serves as the Chairman (since 2017) and Chief Executive Officer of McCormick (since 2016). He previously served as President as well (from 2015 until 2022) and in a variety of other roles with the Company, thereby gaining an understanding of the different aspects of the Company's operations and the food industry. Prior to assuming his present role, Mr. Kurzius was (a) President and Chief Operating Officer (2015 to 2016) of McCormick, (b) President of the Company's global consumer business (2013 to 2016), (c) Chief Administrative Officer of the Company (2013 to 2015), (d) President of the Company's international business (2008 to 2013), (e) President of EMEA (2007 to 2008), (f) President of U.S. Consumer Foods (2005 to 2007), (g) Vice President and General Manager of Sales and Marketing for U.S. Consumer Foods (2005), and (h) President of Zatarain's (2003 to 2005). Prior to joining the Company upon the acquisition of Zatarain's by McCormick, Mr. Kurzius was the Chief Executive Officer of Zatarain's where he worked for 12 years. Mr. Kurzius was also a marketing executive with the Quaker Oats Company and Mars Inc.'s Uncle Ben's Company. In these various roles, Mr. Kurzius developed a broad knowledge of the Company's markets – both domestic and international, and consumer and flavor solutions – and had senior level responsibility for strategic planning and leadership with respect to these businesses. In his present role, Mr. Kurzius is responsible for the strategic leadership of the Company. He has extensive knowledge of consumer goods marketing in general, with a specific knowledge of the business, markets, and customers within the food industry in particular, and has hands-on experience in directing the day-to-day operations of Mccormick & Company, Incorporated large, multi-faceted, consumer and flavor solutions foods business. Mr. Kurzius currently serves on the board of Elanco Animal Health Inc.
高管简历
中英对照 | 中文 | 英文- Albert G. White III
Albert G. White III，2011年7月以来一直担任首席战略官；在2006年4月加入公司以来任副总裁。他之前从2007年11月到2007年3月担任副总裁，负责投资者关系。他还从2006年4月到2006年12月担任会计。在加入公司之前，他曾担任KeyBanc资本市场主管达三年，前八年在KeyBank全国协会担任领导职务。
Albert G. White III,has served as President & Chief Executive Officer and a member of The Cooper Companies, Inc. Board of Directors since May 2018. Previously, he served as Chief Financial Officer from November 2016 until his appointment as CEO and he also served as Executive Vice President and Chief Strategy Officer, positions he held from December 2015 and July 2011, respectively. From August 2015 to May 2018, Mr. White also directed The Cooper Companies, Inc. women's healthcare business and served as Chief Executive Officer of Cooper Medical Inc., the parent company to CooperSurgical. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.- Albert G. White III，2011年7月以来一直担任首席战略官；在2006年4月加入公司以来任副总裁。他之前从2007年11月到2007年3月担任副总裁，负责投资者关系。他还从2006年4月到2006年12月担任会计。在加入公司之前，他曾担任KeyBanc资本市场主管达三年，前八年在KeyBank全国协会担任领导职务。
- Albert G. White III,has served as President & Chief Executive Officer and a member of The Cooper Companies, Inc. Board of Directors since May 2018. Previously, he served as Chief Financial Officer from November 2016 until his appointment as CEO and he also served as Executive Vice President and Chief Strategy Officer, positions he held from December 2015 and July 2011, respectively. From August 2015 to May 2018, Mr. White also directed The Cooper Companies, Inc. women's healthcare business and served as Chief Executive Officer of Cooper Medical Inc., the parent company to CooperSurgical. Previously, he served as Vice President, Investor Relations from November 2007 through March 2013 and as Vice President and Treasurer from April 2006 through December 2012. Prior to joining the Company, Mr. White was a Director with KeyBanc Capital Markets for three years and held a number of leadership positions within KeyBank National Association over the prior eight years.
- Brian G. Andrews
Brian G. Andrews于2020年12月起担任执行副总裁兼首席财务官兼财务主管。他此前于2018年5月起担任The Cooper Companies, Inc.高级副总裁、首席财务官兼财务主管，2013年1月起担任财务主管，2014年11月起担任副总裁。2017年6月至2018年5月，他还担任CooperSurgical全球物流和服务副总裁。Andrews先生曾于2006年4月至2012年12月担任公司助理财务主任。在加入Cooper之前，他曾于2002年至2006年在KeyBanc Capital Markets和2000年至2001年在ING Barings担任多个公司和投资银行职位。他拥有哥伦比亚大学经济学学士学位。
Brian G. Andrews,has served as Executive Vice President, Chief Financial Officer & Treasurer since December 2020. He previously served as The Cooper Companies, Inc. Senior Vice President, Chief Financial Officer & Treasurer from May 2018, and as Treasurer since January 2013 and Vice President since November 2014. He also served as Vice President, Global Logistics and Service for CooperSurgical, a position he held from June 2017 to May 2018. Mr. Andrews previously served as Assistant Treasurer for the Company from April 2006 to December 2012. Prior to joining Cooper, he held various corporate and investment banking positions at KeyBanc Capital Markets from 2002 to 2006 and at ING Barings from 2000 to 2001. He holds a B.A. in Economics from Columbia University.- Brian G. Andrews于2020年12月起担任执行副总裁兼首席财务官兼财务主管。他此前于2018年5月起担任The Cooper Companies, Inc.高级副总裁、首席财务官兼财务主管，2013年1月起担任财务主管，2014年11月起担任副总裁。2017年6月至2018年5月，他还担任CooperSurgical全球物流和服务副总裁。Andrews先生曾于2006年4月至2012年12月担任公司助理财务主任。在加入Cooper之前，他曾于2002年至2006年在KeyBanc Capital Markets和2000年至2001年在ING Barings担任多个公司和投资银行职位。他拥有哥伦比亚大学经济学学士学位。
- Brian G. Andrews,has served as Executive Vice President, Chief Financial Officer & Treasurer since December 2020. He previously served as The Cooper Companies, Inc. Senior Vice President, Chief Financial Officer & Treasurer from May 2018, and as Treasurer since January 2013 and Vice President since November 2014. He also served as Vice President, Global Logistics and Service for CooperSurgical, a position he held from June 2017 to May 2018. Mr. Andrews previously served as Assistant Treasurer for the Company from April 2006 to December 2012. Prior to joining Cooper, he held various corporate and investment banking positions at KeyBanc Capital Markets from 2002 to 2006 and at ING Barings from 2000 to 2001. He holds a B.A. in Economics from Columbia University.
- Holly R. Sheffield
Holly R. Sheffield于2018年6月加入库柏，担任执行副总裁兼首席战略官。在加入Cooper之前，谢菲尔德女士在投资银行领域拥有20多年的经验。 她于2009年至2018年5月从瑞银证券有限公司（UBS Securities LLC）加盟库珀，担任董事总经理，全球医疗技术主管。从2000年至2009年，谢菲尔德女士在瑞士信贷任职；从1997年至2000年，谢菲尔德女士在卢夫金唐纳森任职。 ＆Jenrette，直到被瑞士信贷收购。 谢菲尔德女士获得学士学位 获康奈尔大学（Cornell University）学位，并获得哥伦比亚商学院（Columbia Business School）的工商管理硕士学位。
Holly R. Sheffield has served as President of CooperSurgical, Inc., women's healthcare business, since July 2020. Previously, she served as Executive Vice President & Chief Strategy Officer from June 2018 to July 2020. Prior to joining Cooper, Ms. Sheffield had over 20 years of experience in investment banking. She joined Cooper from UBS Securities LLC, where she was a Managing Director, Global Head of Medical Technology from 2009 to May 2018. From 2000 to 2009 Ms. Sheffield was at Credit Suisse and from 1997 to 2000 Ms. Sheffield was at Donaldson, Lufkin & Jenrette until Credit Suisse acquired the firm. Ms. Sheffield currently serves on the board of Imperative Care, Inc., a private medical device company, and serves on the audit committee. She received a B.S. from Cornell University and an M.B.A. from Columbia Business School.- Holly R. Sheffield于2018年6月加入库柏，担任执行副总裁兼首席战略官。在加入Cooper之前，谢菲尔德女士在投资银行领域拥有20多年的经验。 她于2009年至2018年5月从瑞银证券有限公司（UBS Securities LLC）加盟库珀，担任董事总经理，全球医疗技术主管。从2000年至2009年，谢菲尔德女士在瑞士信贷任职；从1997年至2000年，谢菲尔德女士在卢夫金唐纳森任职。 ＆Jenrette，直到被瑞士信贷收购。 谢菲尔德女士获得学士学位 获康奈尔大学（Cornell University）学位，并获得哥伦比亚商学院（Columbia Business School）的工商管理硕士学位。
- Holly R. Sheffield has served as President of CooperSurgical, Inc., women's healthcare business, since July 2020. Previously, she served as Executive Vice President & Chief Strategy Officer from June 2018 to July 2020. Prior to joining Cooper, Ms. Sheffield had over 20 years of experience in investment banking. She joined Cooper from UBS Securities LLC, where she was a Managing Director, Global Head of Medical Technology from 2009 to May 2018. From 2000 to 2009 Ms. Sheffield was at Credit Suisse and from 1997 to 2000 Ms. Sheffield was at Donaldson, Lufkin & Jenrette until Credit Suisse acquired the firm. Ms. Sheffield currently serves on the board of Imperative Care, Inc., a private medical device company, and serves on the audit committee. She received a B.S. from Cornell University and an M.B.A. from Columbia Business School.
- Gerard H. Warner III
Gerard H. Warner III 自2022年2月起担任CooperVision，Inc.总裁。他曾于2019年4月至2022年1月担任CooperVision美洲和全球商业职能执行副总裁，并于2015年5月至2019年3月担任美洲总裁。2012年5月至2015年4月，Warner曾在CooperVision担任过多个其他副总裁和高级副总裁职位。在加入CooperVision之前，H. Warner曾在博士伦担任过17年的营销和管理职务。Warner先生获得了理科学士学位——来自维拉诺瓦大学的商业管理和罗切斯特大学西蒙商学院的工商管理硕士学位。
Gerard H. Warner III has served as President, CooperVision, Inc. from February 2022. He previously served as Executive Vice President, Americas & Global Commercial Functions of CooperVision from April 2019 to January 2022 and as President, Americas from May 2015 to March 2019. Mr. Warner served in various other Vice President and Senior Vice President positions with CooperVision from May 2012 through April 2015. Prior to joining CooperVision, Mr. Warner spent 17 years at Bausch + Lomb in a variety of marketing and management roles. Mr. Warner earned a Bachelor of Science - Business Administration in Marketing from Villanova University and an MBA from The Simon School of Business - University of Rochester.- Gerard H. Warner III 自2022年2月起担任CooperVision，Inc.总裁。他曾于2019年4月至2022年1月担任CooperVision美洲和全球商业职能执行副总裁，并于2015年5月至2019年3月担任美洲总裁。2012年5月至2015年4月，Warner曾在CooperVision担任过多个其他副总裁和高级副总裁职位。在加入CooperVision之前，H. Warner曾在博士伦担任过17年的营销和管理职务。Warner先生获得了理科学士学位——来自维拉诺瓦大学的商业管理和罗切斯特大学西蒙商学院的工商管理硕士学位。
- Gerard H. Warner III has served as President, CooperVision, Inc. from February 2022. He previously served as Executive Vice President, Americas & Global Commercial Functions of CooperVision from April 2019 to January 2022 and as President, Americas from May 2015 to March 2019. Mr. Warner served in various other Vice President and Senior Vice President positions with CooperVision from May 2012 through April 2015. Prior to joining CooperVision, Mr. Warner spent 17 years at Bausch + Lomb in a variety of marketing and management roles. Mr. Warner earned a Bachelor of Science - Business Administration in Marketing from Villanova University and an MBA from The Simon School of Business - University of Rochester.
- Daniel G. Mcbride
Daniel G. Mcbride 自 2013 年 11 月起担任执行副总裁兼首席运营官，并于 2014 年 2 月至 2022 年 2 月担任 The Cooper Companies, Inc. 的隐形眼镜业务 CooperVision 总裁。他曾担任 The Cooper Companies , Inc. 的首席风险官，从 2011 年 7 月到 2013 年 10 月，从 2007 年 11 月到 2014 年 1 月，担任 The Cooper Companies, Inc. 的总法律顾问，从 2006 年 7 月到 2013 年 10 月，担任副总裁。他从 2005 年 2 月起担任高级法律顾问 至 2007 年 11 月。在加入固铂之前，McBride 先生于 1998 年 10 月至 2005 年 2 月期间在 Latham & Watkins LLP 担任律师，专注于并购和企业融资事务。 他拥有学士学位。 圣克拉拉大学金融学博士和斯坦福法学院法学博士。
Daniel G. Mcbride,has served as Executive Vice President and Chief Operating Officer since November 2013. He also served as interim General Counsel and Secretary from March 2022 through July 2022. He previously served as President of CooperVision, The Cooper Companies, Inc. contact lens business, from February 2014 through February 2022, as The Cooper Companies, Inc. Chief Risk Officer from July 2011 through October 2013, as The Cooper Companies, Inc. General Counsel from November 2007 through January 2014, and as Vice President from July 2006 through October 2013. He served as Senior Counsel from February 2005 through November 2007. Prior to joining Cooper, Mr. McBride was an attorney with Latham & Watkins LLP from October 1998 to February 2005, concentrating on mergers and acquisitions and corporate finance matters. He holds a B.S. in Finance from Santa Clara University and a J.D. from Stanford Law School.- Daniel G. Mcbride 自 2013 年 11 月起担任执行副总裁兼首席运营官，并于 2014 年 2 月至 2022 年 2 月担任 The Cooper Companies, Inc. 的隐形眼镜业务 CooperVision 总裁。他曾担任 The Cooper Companies , Inc. 的首席风险官，从 2011 年 7 月到 2013 年 10 月，从 2007 年 11 月到 2014 年 1 月，担任 The Cooper Companies, Inc. 的总法律顾问，从 2006 年 7 月到 2013 年 10 月，担任副总裁。他从 2005 年 2 月起担任高级法律顾问 至 2007 年 11 月。在加入固铂之前，McBride 先生于 1998 年 10 月至 2005 年 2 月期间在 Latham & Watkins LLP 担任律师，专注于并购和企业融资事务。 他拥有学士学位。 圣克拉拉大学金融学博士和斯坦福法学院法学博士。
- Daniel G. Mcbride,has served as Executive Vice President and Chief Operating Officer since November 2013. He also served as interim General Counsel and Secretary from March 2022 through July 2022. He previously served as President of CooperVision, The Cooper Companies, Inc. contact lens business, from February 2014 through February 2022, as The Cooper Companies, Inc. Chief Risk Officer from July 2011 through October 2013, as The Cooper Companies, Inc. General Counsel from November 2007 through January 2014, and as Vice President from July 2006 through October 2013. He served as Senior Counsel from February 2005 through November 2007. Prior to joining Cooper, Mr. McBride was an attorney with Latham & Watkins LLP from October 1998 to February 2005, concentrating on mergers and acquisitions and corporate finance matters. He holds a B.S. in Finance from Santa Clara University and a J.D. from Stanford Law School.